Loading...
Home Page 2017-06-16T12:17:23+00:00
Design

The Future of Healthcare

Humans have spent centuries looking to create novel therapies to help extend and increase the well-being or our lives for the present and future generations. With the advancement in molecular and cell biology, the power of true healing is being revealed in our own cells.

Design

Human Cell and Tissue Products

Research has show that the use of human cell and tissue products from umbilical cord and other birth tissues could potentially have a disruptive affect on the way certain injuries and human ailments are treated.

Sliders

Proprietary Processing

Predictive utilizes advanced tissue harvesting techniques to create the best minimally manipulated allograft tissue products.  Our tissue donor program performs extensive background checks and testing in order to ensure the quality of the donation.

Options

Quality and Experience

Predicitive’s team of research scientist and technicians have decades of experience with the processing of MSC and cell biology.  We are working tirelessly to convert the latest and greatest scientific discoveries into viable therapies for the masses.

Learn More

Predictive Biotech a Leading provider of novel allograft tissue products

Our flagship allograft CoreCyte™ is isolated from a homogenous population of mesenchymal stromal cells from umbilical cord tissue.
Learn More

Products

CoreCyte™ is a flowable allograft suspension derived from the umbilical cord tissue. CoreCyte™ contains a high concentration of growth factors, proteins, cytokines, and other cellular by-products that help the proliferation of the patients own regenerative capabilities. The allograft is donated and recovered from C-section procedures and the allograft can be transplanted by physicians for several clinical applications including: TMJ, Sports Medicine, Wound and Pain Management treatments.

PolyCyte™ is an allograft suspension product that is a flowable form of Wharton’s Jelly derived from the umbilical tissue. The allograft is donated and recovered from C-section procedures and the allograft can be transplanted by physicians for several clinical applications including: TMJ, Sports Medicine, Wound and Pain Management treatments, and orthopedic procedures.

AmnioCyte™ is an allograft suspension product has been assayed and contains Hyaluronic Acid, Proteins and Cytokines derived from Amniotic Fluid. The allograft is donated and recovered from C-section procedures and the allograft can be transplanted by physicians for several clinical applications including: TMJ, Sports Medicine, Wound and Pain Management treatments.

AmnioCyte Plus™ is an allograft from donated human tissue intended to provide the extracellular matrix needed for the infiltration, attachment and proliferation of cells required for the repair of damaged tissue.  Amniotic tissue allografts have been shown to reduce scarring, fibrosis, and adhesions in surgical and wound sites.  It has also been shown to promote tissue regeneration by providing an anti-microbial and anti-inflammatory environment at surgical and wound sites.

CoreCyte™, PolyCyte™, AmnioCyte™ and AmnioCyte Plus™ are processed from donated human tissue from full term deliveries and is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Follow us for updates and news!